The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Absorbable Embolization Particles Market Research Report 2025
Synopsis
Absorbable embolization particles are biocompatible materials used in medical procedures to induce embolization, a process of blocking blood vessels or other fluid-carrying channels.
The global Absorbable Embolization Particles market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Absorbable Embolization Particles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Absorbable Embolization Particles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Absorbable Embolization Particles include Merit Medical Systems, Medtronic, Boston Scientific, Terumo, Sirtex Medical, ABK Biomedical, BTG Medical, Cook Medical and Teleflex, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Absorbable Embolization Particles, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Absorbable Embolization Particles.
Report Scope
The Absorbable Embolization Particles market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Absorbable Embolization Particles market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Absorbable Embolization Particles manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merit Medical Systems
Medtronic
Boston Scientific
Terumo
Sirtex Medical
ABK Biomedical
BTG Medical
Cook Medical
Teleflex
Nexsphere
Penumbra
Varian
Segment by Type
Polyvinyl Alcohol (PVA) Particles
Trisacryl Gelatin Particles
Others
Segment by Application
Uterine Fibroid Embolization (UFE)
Liver Tumor Embolization
Arteriovenous Malformation (AVM) Embolization
Hemorrhage Control
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Absorbable Embolization Particles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Absorbable Embolization Particles in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Absorbable embolization particles are biocompatible materials used in medical procedures to induce embolization, a process of blocking blood vessels or other fluid-carrying channels.
The global Absorbable Embolization Particles market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Absorbable Embolization Particles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Absorbable Embolization Particles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Absorbable Embolization Particles include Merit Medical Systems, Medtronic, Boston Scientific, Terumo, Sirtex Medical, ABK Biomedical, BTG Medical, Cook Medical and Teleflex, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Absorbable Embolization Particles, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Absorbable Embolization Particles.
Report Scope
The Absorbable Embolization Particles market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Absorbable Embolization Particles market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Absorbable Embolization Particles manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merit Medical Systems
Medtronic
Boston Scientific
Terumo
Sirtex Medical
ABK Biomedical
BTG Medical
Cook Medical
Teleflex
Nexsphere
Penumbra
Varian
Segment by Type
Polyvinyl Alcohol (PVA) Particles
Trisacryl Gelatin Particles
Others
Segment by Application
Uterine Fibroid Embolization (UFE)
Liver Tumor Embolization
Arteriovenous Malformation (AVM) Embolization
Hemorrhage Control
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Absorbable Embolization Particles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Absorbable Embolization Particles in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Absorbable Embolization Particles Market Overview
1.1 Product Overview and Scope of Absorbable Embolization Particles
1.2 Absorbable Embolization Particles Segment by Type
1.2.1 Global Absorbable Embolization Particles Market Value Comparison by Type (2024-2030)
1.2.2 Polyvinyl Alcohol (PVA) Particles
1.2.3 Trisacryl Gelatin Particles
1.2.4 Others
1.3 Absorbable Embolization Particles Segment by Application
1.3.1 Global Absorbable Embolization Particles Market Value by Application: (2024-2030)
1.3.2 Uterine Fibroid Embolization (UFE)
1.3.3 Liver Tumor Embolization
1.3.4 Arteriovenous Malformation (AVM) Embolization
1.3.5 Hemorrhage Control
1.3.6 Others
1.4 Global Absorbable Embolization Particles Market Size Estimates and Forecasts
1.4.1 Global Absorbable Embolization Particles Revenue 2019-2030
1.4.2 Global Absorbable Embolization Particles Sales 2019-2030
1.4.3 Global Absorbable Embolization Particles Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Absorbable Embolization Particles Market Competition by Manufacturers
2.1 Global Absorbable Embolization Particles Sales Market Share by Manufacturers (2019-2024)
2.2 Global Absorbable Embolization Particles Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Absorbable Embolization Particles Average Price by Manufacturers (2019-2024)
2.4 Global Absorbable Embolization Particles Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Absorbable Embolization Particles, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Absorbable Embolization Particles, Product Type & Application
2.7 Absorbable Embolization Particles Market Competitive Situation and Trends
2.7.1 Absorbable Embolization Particles Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Absorbable Embolization Particles Players Market Share by Revenue
2.7.3 Global Absorbable Embolization Particles Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Absorbable Embolization Particles Retrospective Market Scenario by Region
3.1 Global Absorbable Embolization Particles Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Absorbable Embolization Particles Global Absorbable Embolization Particles Sales by Region: 2019-2030
3.2.1 Global Absorbable Embolization Particles Sales by Region: 2019-2024
3.2.2 Global Absorbable Embolization Particles Sales by Region: 2025-2030
3.3 Global Absorbable Embolization Particles Global Absorbable Embolization Particles Revenue by Region: 2019-2030
3.3.1 Global Absorbable Embolization Particles Revenue by Region: 2019-2024
3.3.2 Global Absorbable Embolization Particles Revenue by Region: 2025-2030
3.4 North America Absorbable Embolization Particles Market Facts & Figures by Country
3.4.1 North America Absorbable Embolization Particles Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Absorbable Embolization Particles Sales by Country (2019-2030)
3.4.3 North America Absorbable Embolization Particles Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Absorbable Embolization Particles Market Facts & Figures by Country
3.5.1 Europe Absorbable Embolization Particles Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Absorbable Embolization Particles Sales by Country (2019-2030)
3.5.3 Europe Absorbable Embolization Particles Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Absorbable Embolization Particles Market Facts & Figures by Country
3.6.1 Asia Pacific Absorbable Embolization Particles Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Absorbable Embolization Particles Sales by Country (2019-2030)
3.6.3 Asia Pacific Absorbable Embolization Particles Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Absorbable Embolization Particles Market Facts & Figures by Country
3.7.1 Latin America Absorbable Embolization Particles Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Absorbable Embolization Particles Sales by Country (2019-2030)
3.7.3 Latin America Absorbable Embolization Particles Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Absorbable Embolization Particles Market Facts & Figures by Country
3.8.1 Middle East and Africa Absorbable Embolization Particles Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Absorbable Embolization Particles Sales by Country (2019-2030)
3.8.3 Middle East and Africa Absorbable Embolization Particles Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Absorbable Embolization Particles Sales by Type (2019-2030)
4.1.1 Global Absorbable Embolization Particles Sales by Type (2019-2024)
4.1.2 Global Absorbable Embolization Particles Sales by Type (2025-2030)
4.1.3 Global Absorbable Embolization Particles Sales Market Share by Type (2019-2030)
4.2 Global Absorbable Embolization Particles Revenue by Type (2019-2030)
4.2.1 Global Absorbable Embolization Particles Revenue by Type (2019-2024)
4.2.2 Global Absorbable Embolization Particles Revenue by Type (2025-2030)
4.2.3 Global Absorbable Embolization Particles Revenue Market Share by Type (2019-2030)
4.3 Global Absorbable Embolization Particles Price by Type (2019-2030)
5 Segment by Application
5.1 Global Absorbable Embolization Particles Sales by Application (2019-2030)
5.1.1 Global Absorbable Embolization Particles Sales by Application (2019-2024)
5.1.2 Global Absorbable Embolization Particles Sales by Application (2025-2030)
5.1.3 Global Absorbable Embolization Particles Sales Market Share by Application (2019-2030)
5.2 Global Absorbable Embolization Particles Revenue by Application (2019-2030)
5.2.1 Global Absorbable Embolization Particles Revenue by Application (2019-2024)
5.2.2 Global Absorbable Embolization Particles Revenue by Application (2025-2030)
5.2.3 Global Absorbable Embolization Particles Revenue Market Share by Application (2019-2030)
5.3 Global Absorbable Embolization Particles Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merit Medical Systems
6.1.1 Merit Medical Systems Corporation Information
6.1.2 Merit Medical Systems Description and Business Overview
6.1.3 Merit Medical Systems Absorbable Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merit Medical Systems Absorbable Embolization Particles Product Portfolio
6.1.5 Merit Medical Systems Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Absorbable Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Absorbable Embolization Particles Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Corporation Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Absorbable Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boston Scientific Absorbable Embolization Particles Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 Terumo
6.4.1 Terumo Corporation Information
6.4.2 Terumo Description and Business Overview
6.4.3 Terumo Absorbable Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Terumo Absorbable Embolization Particles Product Portfolio
6.4.5 Terumo Recent Developments/Updates
6.5 Sirtex Medical
6.5.1 Sirtex Medical Corporation Information
6.5.2 Sirtex Medical Description and Business Overview
6.5.3 Sirtex Medical Absorbable Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sirtex Medical Absorbable Embolization Particles Product Portfolio
6.5.5 Sirtex Medical Recent Developments/Updates
6.6 ABK Biomedical
6.6.1 ABK Biomedical Corporation Information
6.6.2 ABK Biomedical Description and Business Overview
6.6.3 ABK Biomedical Absorbable Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ABK Biomedical Absorbable Embolization Particles Product Portfolio
6.6.5 ABK Biomedical Recent Developments/Updates
6.7 BTG Medical
6.6.1 BTG Medical Corporation Information
6.6.2 BTG Medical Description and Business Overview
6.6.3 BTG Medical Absorbable Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BTG Medical Absorbable Embolization Particles Product Portfolio
6.7.5 BTG Medical Recent Developments/Updates
6.8 Cook Medical
6.8.1 Cook Medical Corporation Information
6.8.2 Cook Medical Description and Business Overview
6.8.3 Cook Medical Absorbable Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cook Medical Absorbable Embolization Particles Product Portfolio
6.8.5 Cook Medical Recent Developments/Updates
6.9 Teleflex
6.9.1 Teleflex Corporation Information
6.9.2 Teleflex Description and Business Overview
6.9.3 Teleflex Absorbable Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teleflex Absorbable Embolization Particles Product Portfolio
6.9.5 Teleflex Recent Developments/Updates
6.10 Nexsphere
6.10.1 Nexsphere Corporation Information
6.10.2 Nexsphere Description and Business Overview
6.10.3 Nexsphere Absorbable Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nexsphere Absorbable Embolization Particles Product Portfolio
6.10.5 Nexsphere Recent Developments/Updates
6.11 Penumbra
6.11.1 Penumbra Corporation Information
6.11.2 Penumbra Absorbable Embolization Particles Description and Business Overview
6.11.3 Penumbra Absorbable Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Penumbra Absorbable Embolization Particles Product Portfolio
6.11.5 Penumbra Recent Developments/Updates
6.12 Varian
6.12.1 Varian Corporation Information
6.12.2 Varian Absorbable Embolization Particles Description and Business Overview
6.12.3 Varian Absorbable Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Varian Absorbable Embolization Particles Product Portfolio
6.12.5 Varian Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Absorbable Embolization Particles Industry Chain Analysis
7.2 Absorbable Embolization Particles Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Absorbable Embolization Particles Production Mode & Process
7.4 Absorbable Embolization Particles Sales and Marketing
7.4.1 Absorbable Embolization Particles Sales Channels
7.4.2 Absorbable Embolization Particles Distributors
7.5 Absorbable Embolization Particles Customers
8 Absorbable Embolization Particles Market Dynamics
8.1 Absorbable Embolization Particles Industry Trends
8.2 Absorbable Embolization Particles Market Drivers
8.3 Absorbable Embolization Particles Market Challenges
8.4 Absorbable Embolization Particles Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
